Moneycontrol PRO
LAMF
LAMF
Jump to
  • Have strong order book; life science business stands at USD 151m, says Take Solutions

  • Confident of 25% organic growth for next 3 years: Take Solutions

  • TAKE issues Q3 warning on Chennai, says full-year on track

  • Will improve margins, grow over 20% in FY16: Take Solutions

  • See EBITDA in 22-23% range in FY12: Take Solutions

    In an interview with CNBC-TV18, HR Srinivasan, VC, prime founder of Take Solutions said, the company’s current order book stands at USD 72.5 million. “During the course of this year, our earnings before interest, taxes, depreciation and amortization (EBITDA) will be in the 22-23% range."

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347